Not Cleared Post-NSE

DEN030005 - FACTOR V LEIDEN KIT (FDA 510(k) Clearance)

Dec 2003
Decision
9d
Days
Class 2
Risk

DEN030005 is an FDA 510(k) submission for the FACTOR V LEIDEN KIT. This device is classified as a Test, Factor V Leiden Mutations, Genomic Dna Pcr (Class II - Special Controls, product code NPQ).

Submitted by Roche Diagnostics Corp. (Indianapolis, US). The FDA issued a Not Cleared (DENG) decision on December 17, 2003.

This device falls under the Pathology FDA review panel. Regulated under 21 CFR 864.7280. In Vitro Diagnostic Test To Detect The Factor V Leiden Mutation In Genomic Dna, As An Aid To Diagnosis In The Evaluation Of Patients With Suspected Thrombophilia..

Submission Details

510(k) Number DEN030005 FDA.gov
FDA Decision Not Cleared Not Substantially Equivalent (DENG)
Date Received December 08, 2003
Decision Date December 17, 2003
Days to Decision 9 days
Submission Type Post-NSE
Review Panel Pathology (PA)
Summary

Device Classification

Product Code NPQ — Test, Factor V Leiden Mutations, Genomic Dna Pcr
Device Class Class II - Special Controls
CFR Regulation 21 CFR 864.7280
Definition In Vitro Diagnostic Test To Detect The Factor V Leiden Mutation In Genomic Dna, As An Aid To Diagnosis In The Evaluation Of Patients With Suspected Thrombophilia.